Home > Quotes > PFNX

Pfenex Inc. Common Stock Quote & Summary Data

Get PFNX Alerts
*Delayed - data as of May 3, 2016 14:53 ET  -  Find a broker to begin trading PFNX now
Exchange: AMEX
Industry: Health Care
Community Rating:
View:    PFNX Real Time
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
Basic Chart Interactive Chart
Company Headlines Press Releases Market Stream
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Pfenex Inc. Common Stock Intraday Chart

News for PFNX

Shares Traded

Trading Range

Intraday Last 52 Weeks
High $ 8.54 $ 24.41
Low $ 7.85 $ 6.50

The current last sale of $8.50 is 30.77% Higher thanthe 52 week low.

P/E Ratio

Company Description (as filed with the SEC)

We are a clinical-stage biotechnology company engaged in the development of biosimilar and therapeutic equivalent products to branded therapeutics and other high-value and difficult-to-manufacture proteins. Our lead product candidate is PF582, a biosimilar candidate to Lucentis (ranibizumab). Lucentis, marketed by Genentech, Inc., a wholly-owned member of the Roche Group and Novartis AG, for the treatment of patients with retinal diseases, achieved approximately $4.5 billion in global product sales in 2014. For PF582, we are conducting a Phase 1b/2a trial in patients with wet age-related macular degeneration, or wet AMD, with our collaboration partner, Hospira, Inc., or Hospira, a subsidiary of Pfizer Inc. (collectively with Hospira, "Pfizer"). Pfizer is responsible for manufacturing, clinical studies and commercialization of PF582 globally upon successful receipt of marketing approval. Our next most advanced product candidates are PF530 and PF708.  ... More ...  

Risk Grade

Where does PFNX fit in the risk graph?

Risk Grade Scale

Consensus Recommendation

Research Brokers before you trade

Want to trade FX?